Glycogen Storage Disease Type I
(Gierke Disease)
By
HASNAT MUEEN
, Table of Contents
1 Discovery: ........................................................................................................................... 3
2 Types: ................................................................................................................................. 3
2.1 GSD IA:....................................................................................................................... 3
2.2 GSD IB: ....................................................................................................................... 3
3 Cause: ................................................................................................................................. 3
4 Metabolic effects (pathophysiology): ................................................................................. 4
4.1 Fasting hypoglycemia: ................................................................................................ 4
4.2 Lactic Acidemia: ......................................................................................................... 4
4.3 Hypertriglyceridemia: ................................................................................................. 4
4.4 Hyperuricemia: ............................................................................................................ 4
5 Signs and symptoms: .......................................................................................................... 5
6 Associated Disorders: ......................................................................................................... 5
7 Diagnosis: ........................................................................................................................... 6
8 Frequency of Occurring: ..................................................................................................... 6
9 Treatment: ........................................................................................................................... 6
(Gierke Disease)
By
HASNAT MUEEN
, Table of Contents
1 Discovery: ........................................................................................................................... 3
2 Types: ................................................................................................................................. 3
2.1 GSD IA:....................................................................................................................... 3
2.2 GSD IB: ....................................................................................................................... 3
3 Cause: ................................................................................................................................. 3
4 Metabolic effects (pathophysiology): ................................................................................. 4
4.1 Fasting hypoglycemia: ................................................................................................ 4
4.2 Lactic Acidemia: ......................................................................................................... 4
4.3 Hypertriglyceridemia: ................................................................................................. 4
4.4 Hyperuricemia: ............................................................................................................ 4
5 Signs and symptoms: .......................................................................................................... 5
6 Associated Disorders: ......................................................................................................... 5
7 Diagnosis: ........................................................................................................................... 6
8 Frequency of Occurring: ..................................................................................................... 6
9 Treatment: ........................................................................................................................... 6
